LEI 5493006QSC6RF6SEU438

F. Hoffmann-La Roche AG

Awards tracked

69

Value

€2.8M

Countries

CH

Download sample CSV

Contract awards & public grants

Cardio-Oncology Multidisciplinary Patient ASsistance Solution → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2026-03-25

—

Breakthrough Regulatory Innovation and Development throuGh sandbox Environments → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2025-11-07

—

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2025-11-03

—

Advancing Equity, Diversity and Inclusion in Clinical Trials → F. Hoffmann-La Roche AG

European Commission · CH · Grant · 2025-06-27

—

Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT) → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-12-16

—

Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-12-12

—

REpresentative Clinical Research - ADvancing Inclusivity in Europe → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-12-05

—

Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-11-12

—

The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-10-24

—

EUROPEAN RARE DISEASES RESEARCH ALLIANCE → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-08-20

—

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-07-26

—

Macrocycles for Drug Discovery → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2024-07-10

—

A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-12-11

—

Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-11-16

—

Framework to IMPROVE the Integration of Patient Generated Health Data to Facilitate Value Based Healthcare → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-11-10

—

INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-10-20

—

Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-06-23

—

GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-05-17

—

CLinical impact through AI-assisted MS care → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-05-15

—

Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2023-05-10

—

From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2022-10-10

—

Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer memb → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2022-07-14

—

Decoding novel reaction chemistries in biocatalysis – Training Europe’s next visionaries for a sustainable future → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2022-07-06

—

Risk and Resilience in Developmental Diversity and Mental Health → F. Hoffmann-La Roche AG

European Commission · CH · Grant · 2022-05-23

—

European platform for neurodegenerative disorders → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2021-10-25

—

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2021-10-18

—

Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2021-10-13

—

FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2021-10-11

—

Understanding the Biology of Human Enteroendocrine Cells → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2021-07-15

€870,285

Real World Handling of Protein Drugs - Exploration, Evaluation and Education → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2021-07-05

—

Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment. → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2021-01-18

—

Central Repository for Digital Pathology → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2020-11-26

—

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2020-11-12

—

H2O Health Outcomes Observatory → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2020-09-30

—

A fully integrated, animal-free, end-to-end modelling approach to oral drug product development → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2020-09-07

€187,518

Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2020-08-18

€281,277

Prioritisation and Risk Evaluation of Medicines in the EnviRonment → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2020-06-24

—

Stratification of Obesity Phenotypes to Optimize Future Therapy → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2020-05-26

—

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-12-18

—

PharmaLedger → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-12-16

—

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-11-18

—

Virtual IoT Maintenance System → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-10-11

€421,103

Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-09-26

—

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-08-22

—

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-08-09

—

Great ape organoids to reconstruct uniquely human development → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-05-03

€1.04M

Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diag → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-04-08

—

Efficiently Networking European Neurodegeneration Research → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2019-02-28

—

European Health Data and Evidence Network → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2018-11-22

—

European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2018-08-30

—

Autism Innovative Medicine Studies – 2 – Trials → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2018-06-22

—

conect4children (COllaborative Network for European Clinical Trials For Children) → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2018-06-22

—

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medici → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2018-06-04

—

Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2017-09-12

—

Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical t → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2017-09-12

—

European Quality In Preclinical Data → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2017-08-18

—

ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2017-05-18

—

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2017-01-30

—

Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2016-12-21

—

Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2016-12-16

—

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2016-10-21

—

International, Interdisciplinary and Intersectoral Postdocs → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2016-05-13

—

Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2015-12-18

—

Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2015-12-09

—

An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2015-09-11

—

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2015-09-02

—

FRAGments training NETwork → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2015-08-11

—

Brain barriers training → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2015-08-03

—

Exploring the combined role of genetic and non-genetic factors for developing Age-Related Macular Degeneration: A systems level analysis of disease su → F. HOFFMANN-LA ROCHE AG

European Commission · CH · Grant · 2015-04-07

—

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.